The Deep Tech Funding Index
Comprehensive venture capital tracking across humanoid robotics, brain-computer interfaces, quantum computing, small modular reactors, and synthetic biology. Aggregated from five dedicated intelligence platforms.
Funding by Sector
Largest Deep Tech Funding Rounds
Top 20 rounds across all sectors, sorted by amount.
| Company | Round | Amount | Sector | Date |
|---|---|---|---|---|
| Orano | Planned Investment | $5B | Small Modular Reactors | 2026-06-01 |
| OPG / BWRX-300 | Investment Deal | CAD $3B | Small Modular Reactors | 2025-10-01 |
| DOE HALEU/LEU Enrichment | Government Program | $2.7B | Small Modular Reactors | 2025-12-01 |
| TerraPower | DOE ARDP Cost-Share | $2B | Small Modular Reactors | 2020-10-01 |
| Figure AI | Series C | $1.5B | Humanoid Robotics | 2026-01-28 |
| Skild AI | Series C | $1.4B | Humanoid Robotics | 2026-01-14 |
| X-energy | DOE ARDP Award | $1.2B | Small Modular Reactors | 2020-10-01 |
| Boston Dynamics | Strategic Acquisition | $1.1B | Humanoid Robotics | 2021-06-21 |
| NEURA Robotics | Series D | €1B (~$1.08B) | Humanoid Robotics | 2026-03-15 |
| Constellation Energy | DOE Loan | $1B | Small Modular Reactors | 2025-11-01 |
| PsiQuantum | Series E | $1B | Quantum Computing | 2025-09-15 |
| IonQ | Public Offering / Follow-on | $1B+ | Quantum Computing | 2025-03-01 |
| Centrus Energy | DOE Task Order | $900M | Small Modular Reactors | 2026-01-15 |
| Mentee Robotics | Acquisition | $900M | Humanoid Robotics | 2026-01-06 |
| X-energy | Series D | $700M | Small Modular Reactors | 2025-11-15 |
| Figure AI | Series D | $675M | Humanoid Robotics | 2025-09-30 |
| Figure AI | Series B | $675M | Humanoid Robotics | 2024-02-29 |
| Neuralink | Series E | $650M | Brain-Computer Interfaces | 2025-06-02 |
| ArsenalBio | Series C | $630M | Synthetic Biology | 2024-01-18 |
| National Resilience | Series B | $625M | Synthetic Biology | 2022-03-22 |
Sector Snapshots
Humanoid Robotics
Humanoid robotics is experiencing a historic venture capital surge. Companies like Figure AI, 1X Technologies, Tesla (Optimus), Agility Robotics, and Apptronik are racing to build general-purpose humanoid robots capable of working alongside humans in warehouses, factories, and homes. The sector has attracted billions in funding as advances in AI, actuator design, and simulation-to-reality transfer make commercially viable humanoids increasingly plausible.
Brain-Computer Interfaces
Brain-computer interfaces are transitioning from research curiosities to clinical products. Neuralink, Synchron, Precision Neuroscience, and Blackrock Neurotech lead the field with devices ranging from intracortical electrode arrays to endovascular stents. FDA Investigational Device Exemptions have been granted to multiple companies, enabling human clinical trials. Investment is driven by applications in ALS communication, spinal cord injury rehabilitation, and emerging consumer neurotechnology.
Quantum Computing
Quantum computing is advancing rapidly toward practical advantage. IBM, Google, Quantinuum, IonQ, PsiQuantum, and dozens of startups are pursuing superconducting, trapped-ion, photonic, and neutral-atom architectures. Error correction milestones achieved in 2024-2025 have accelerated commercialization timelines. The sector has attracted major venture rounds and government funding globally.
Small Modular Reactors
Small modular reactors represent the next generation of nuclear energy. Companies like NuScale Power, X-energy, Kairos Power, TerraPower, and Oklo are developing factory-built reactors that promise safer, faster, and more affordable nuclear deployment. SMRs are gaining regulatory momentum and are increasingly seen as essential for AI data center power and grid decarbonization.
Synthetic Biology
Synthetic biology is engineering biology to manufacture materials, medicines, food, and fuels. Leaders include Ginkgo Bioworks, Twist Bioscience, and Mammoth Biosciences. The field leverages advances in DNA synthesis, CRISPR gene editing, and AI-guided protein design. Applications span biomanufacturing, agriculture, therapeutics, and environmental remediation.